article thumbnail

Global cell line development to surge in next decade

European Pharmaceutical Review

Advancements in biotechnology, pharmaceutical research, and biomanufacturing processes are key factors in driving the market, the author acknowledged. Demand for cell lines “in drug development , vaccine production, and therapeutic research is surging”, setting the market up for significant expansion, Ghosh noted.

article thumbnail

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

PharmaKinnex

PharmaKinnex knows that identifying, qualifying, and then directing leads toward a successful sale is extremely difficult in today’s environment. In the course of attempting to protect prescribers and patients from unfair marketing practices, the pharmaceutical industry has taken steps to limit unfettered access to HCPs and clinics.

Pharma 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Entry-Level Pharma Sales: It's More Than Just a Job Search (Here's Why)

Contrarian Sales Techniques

Reach out to your network: Inform your personal and professional network about your job search and inquire about potential leads or introductions. Regulatory compliance: Familiarize yourself with relevant regulations that govern pharmaceutical sales practices.

Sales 52
article thumbnail

The Future for Biotesting

Pharmaceutical Technology

Now the facility is completely private, owned and governed by five co-owners, which all hold the key positions in the company’s management structure. It will most probably lead to a new anti-flu vaccine. Pharmaceutical research generally, and pre-clinical research in particular, is very dynamic in its development.

article thumbnail

Why Decentralized Clinical Trials Are the Wave of the Future

Salesforce

As the global pharmaceutical lead on Salesforce’s Healthcare and Life Sciences Industry Advisory team, I participated in a roundtable discussion with executives from a number of pharmaceutical and contract research organizations (CRO) on how to move forward with clinical trials. . Support innovation.

article thumbnail

US Democrats’ blockbuster budget bill could spell big changes for drug prices

pharmaphorum

Chief among these provisions is that the bill will allow, and indeed require, Medicare, the US’s government-run insurance program for older Americans, to negotiate drug prices with pharmaceutical companies in some cases, something it historically has not been allowed to do.